Concepedia

Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting

Alejandra Reolid, Susana Armesto, Antonio Sahuquillo‐Torralba, Tiago Torres, Rosa Feltes, Eva Vilarrasa, I. Belinchón, P. de la Cueva, Lourdes Rodríguez, Alberto Romero‐Maté,

Journal of the American Academy of Dermatology · 2022 · 12 citations · 3 references

DOI

Concepts

References

3

Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial

Alice B. Gottlieb, John Sullivan, Martijn B. A. van Doorn et al. · Journal of the American Academy of Dermatology · 2016 · 152 citations · Full text

, , +13

Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study

Ulrich Mrowietz, H. Bachelez, A. David Burden et al. · Journal of the American Academy of Dermatology · 2019 · 142 citations · Full text

, , +13

Sustained efficacy of secukinumab in patients with moderate‐to‐severe palmoplantar psoriasis: 2·5‐year results from <scp>GESTURE</scp> , a randomized, double‐blind, placebo‐controlled trial

Alice B. Gottlieb, Martijn B. A. van Doorn, John Sullivan et al. · British Journal of Dermatology · 2019 · 40 citations

, , +13